Cannabis Law Report

NOVEMBER 22, 2019

MMJ International Holdings, the premier medical cannabis research company, announced that it has received DEA approval to ship THC and CBD from Canada. MMJ International Holdings is developing oral drug products from natural whole plant extract derivatives from the marijuana plant containing THC and CBD.

DEA 66

DEA Clinical Trials THC Research and Development 66

Cannabis Law Report

AUGUST 3, 2021

CSE: MXT) (OTCQB: MXTTF) is known for its award-winning extraction equipment, but recently, the company refocused its efforts on its proprietary health-related databases, machine learning analysis, and plans to engage in B2B licensing and mHealth. Data Bridge Market Research believes that psychedelics will grow at a 13.3%

Research and Development 105

Research and Development Data Conditions Therapy 105

Project CBD

AUGUST 6, 2019

The 29th annual International Cannabinoid Research Society ( ICRS ) symposium, which convened last month in Bethesda, Maryland, featured new developments in CBD science that have far-reaching implications for many areas of medicine. But would tolerance develop with repeated dosing, thereby mitigating CBD ’s hypotensive effect?

CBD 177

CBD Blood Pressure Research and Development Cannabinoids 177

MMJ Recs

MARCH 16, 2024

Economic Growth and Job Creation of the medical marijuana industry The medical cannabis sector serves as a catalyst for economic expansion and workforce development in regions where it’s legalized. Moreover, ensuring product quality and safety throughout the supply chain is paramount to maintain patient trust and regulatory compliance.

Supply Chain 105

Supply Chain Research and Development Marijuana Seed-To-Sale 105

Veriheal

DECEMBER 23, 2022

Researchers Inspected Cannabis Products for Contaminants. Dr. Maxwell’s team also collected data contained in samples sourced from California. There was more inconsistency in cannabis-borne contaminant regulation as compared with other agricultural commodities,” wrote the researchers. for extracts.

Research and Development 92

Research and Development Agriculture Data Extraction 92

CannaMD

MAY 19, 2020

In a working draft of research prepared by Canadian scientists, study authors claim that their findings are “crucial for the future analysis of the effects of medical cannabis on COVID-19.” Hypothesizing that high-CBD cannabis extracts may be used to modulate ACE2 expression in COVID- 19 target tissues, researchers went to work.

Research and Development 131

Research and Development Sativa Marijuana Extraction 131

Cannabis Law Report

JUNE 29, 2021

Desai brings to Ehave the ability to visualize opportunities and execute creative strategic solutions, while developing deep networks and relationships within the industry. Research in the area of mental health has been Dr. Nitin Desai’s passion. Ben Kaplan, CEO of Ehave, Inc. Ehave, Inc. Forward-Looking Statement Disclaimer.

Clinical Trials 105

Clinical Trials Research and Development Data Patients 105

Greencamp

AUGUST 16, 2018

In this comprehensive guide, we are exploring the research on using cannabis for treating Amyotrophic lateral sclerosis (ALS)—a rare neuron disease that targets the motor neurons in the body. Both upper and lower motor neurons suffer severe damage in ALS patients. Exploring the available research on ALS and cannabinoids.

Strains 94

Strains Cannabinoids Research and Development Indica 94

CannaMD

AUGUST 19, 2020

While COVID-19 can be deadly, the World Health Organization (WHO) stresses that most patients experience mild cases and/or survive: Most people who get COVID-19 have mild or moderate symptoms and can recover thanks to supportive care. ” And their alternative strategy of choice? SARS-CoV2 is the virus that causes COVID-19.).

Research and Development 141

Research and Development Marijuana Extraction Terpenes 141

The Joint Blog

MARCH 3, 2021

According to a new study published in the Journal of Cannabis Research, adjunctive marijuana use is associated with improvements in pain and other symptoms in patients with refractory fibromyalgia. For the study researcher examined the long-term use of various types of marijuana preparations (e.g.,

Therapy 61

Therapy Hybrid Marijuana Research and Development 61

Cannabis Law Report

JULY 6, 2021

Johnson’s primary area of research expertise is the psychopharmacology of medications for treating addictions, and he is well known in the field for his discovery that topiramate, a gamma-aminobutyric acid. is a provider of digital therapeutics delivering evidence-based therapeutic interventions to patients. Ehave, Inc.

Research and Development 97

Research and Development Wellness and Beauty Clinical Trials Therapy 97

Veriheal

DECEMBER 28, 2021

Over the last few decades, the cannabis plant and its many components have been the focal point of research and stiff debate. D espite the Drug Enforcement Agency’s (DEA) announcement in May that it would soon start reviewing grower applications for research purposes, cannabis research continues to be tightly restricted.

Research and Development 98

Research and Development Chronic Pain Treatment Medicine 98

The Cannigma

MARCH 2, 2021

This issue is compounded when veterans do, on rare occasions, ask their doctors about medical marijuana, only to be treated as if they are mentally unstable or receive no specific health information at all,” the researchers found. This directly conflicts with past research claiming marijuana increases PTSD symptom severity.”.

Research and Development 143

Research and Development Treatment Chronic Pain Sleep 143

Cannabis Law Report

JULY 29, 2021

OTTAWA, ON , July 29, 2021 /PRNewswire/ – Tetra Bio-Pharma Inc (“Tetra” or the Company”) (TSX: TBP) (OTCQB: TBPMF) (FRA: JAM1), a leader in cannabinoid-based drug discovery and development has announced that it filed a PCT patent application for Cannabis Plant Residue and Use Thereof, PCT Patent Application No.

Research and Development 105

Research and Development Clinical Trials Events Cannabinoids 105

Cannabis Law Report

JANUARY 16, 2022

But Sativex — an oromucosal spray of a formulated cannabis extract with cannabidiol (CBD) as well as THC, the psychoactive chemical component in cannabis — was taken off the Malaysian market three years later as it was not commercially viable. Sativex was developed by GW Pharmaceuticals, a maker of cannabinoid therapeutics based in Ireland.

Research and Development 98

Research and Development Pharmaceutical Epilepsy Medicine 98

The Cannigma

JUNE 23, 2022

And while there is essentially no research to say what CBGA does when taken by humans, CBGA has undergone preliminary (preclinical) research for its effects in seizures, inflammation, diabetes, and even COVID infections. He noted, “The data in the study isn’t really ready for translation to the clinic.” Pain and inflammation.

Cannabinoids 113

Cannabinoids Research and Development Clinical Trials Extraction 113

The Joint Blog

MARCH 18, 2021

According to a new study titled Use of cannabinoids for the treatment of patients with post-traumatic stress disorder, the consumption of cannabinoids and cannabinoid products is safe and effective in the mitigation of symptoms of post-traumatic stress (PTS). Researchers examined studies that used both natural and synthetic THC and CBD.

Cannabinoids 26

Cannabinoids Patients Clinical Trials Research and Development 26

Cannabis Law Report

MAY 18, 2022

Observational Data Collected On Long-term Consumption of Oral C BD Shows No Correlation To Safety Issues Raised by FDA. Validcare contracted with 17 CBD companies and acted as the Contract Research Organization, which included gaining feedback from FDA on the protocol, conducting the study and publishing its results.

Safety 52

Safety Hemp Research and Development Data 52

Cannabis Law Report

JUNE 30, 2021

Despite the high prevalence of these disorders, few patients are accurately screened and diagnosed. For example, research shows that primary care physicians misdiagnosed 65.9% of patients with major depressive disorder, 92.7% of patients with bipolar disorder, 71% of patients with generalized anxiety disorder, and 97.8%

Treatment 52

Treatment Clinical Trials Research and Development Data 52

Cannabis Law Report

MAY 18, 2022

Observational Data Collected On Long-term Consumption of Oral C BD Shows No Correlation To Safety Issues Raised by FDA. Validcare contracted with 17 CBD companies and acted as the Contract Research Organization, which included gaining feedback from FDA on the protocol, conducting the study and publishing its results.

Safety 52

Safety Hemp Research and Development Data 52

The Cannigma

JUNE 15, 2021

Both THC and CBD were first isolated in a laboratory in the early 1940s by American researcher Roger Adams. It wasn’t until the 1960s, however, that Israeli researcher Raphael Mechoulam properly identified the chemical structure of CBD, which led to the wealth of knowledge and scope of research we have today.

CBD 122

CBD Research and Development Epilepsy Extraction 122

Cannabis Law Report

NOVEMBER 28, 2021

Medical cannabis business Equinox International is planning to list on the London Stock Exchange to raise cash for a ‘state-of-the-art’ cultivation, extraction and production facility on a Home Office-approved 20-acre UK site. UK medical cannabis market to have addressable market of £7.5bn by 2028 .

Research and Development 52

Research and Development Business Cultivation Access 52

Cannabis Law Report

AUGUST 11, 2021

(“Avicanna”), a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products. The Branded Products include Avicanna’s proprietary cannabinoid topical formulations developed through years of extensive research by Avicanna’s team of scientists.

Topical 98

Topical Research and Development Seed-To-Sale Pharmaceutical 98

Cannabis Law Report

JULY 24, 2022

According to experts, research with psychedelics (also known as hallucinogens) or related substances will increase worldwide in the coming years. The legal framework regarding the use of psychedelics in patients is very pragmatic in Switzerland and unique internationally. Psilocybin was first extracted and identified in 1958.

Research and Development 52

Research and Development Legalization Treatment Patients 52

Cannabis Law Report

DECEMBER 7, 2021

Adverse mental events were reported as well, however, more research should be performed to assess well this outcome. However, despite the increased use of MCs in children, there is limited data regarding their safety and efficacy in this population for those different indications 11. Data extraction. Introduction.

Safety 52

Safety Cannabinoids Events Data 52

The Joint Blog

JULY 17, 2020

According to a new study published in the journal Seminars in Pediatric Neurology, marijuana-based products are associated with improvements in the symptoms of autistic patients who have self-injurious behaviors and co-morbid epilepsy. The study is titled Autism Spectrum Disorder and medical cannabis: Review & clinical experience.

Epilepsy 47

Epilepsy Research and Development Marijuana Treatment 47

Otherside Farms

JULY 4, 2022

Decarboxylation of CBCa (cannabichromene carboxylic acid) from CBGa (cannabigerol acid) results in this CBC extract. In this study, researchers examined studied Bulk CBC Isolate and paw edema. The researchers studied adult mice neural stem progenitor cells (NSPCs) outside the body. The cannabinoid reduces edema. Antibacterial.

Research and Development 96

Research and Development Cannabinoids THC Concentrates 96

Cannabis Law Report

SEPTEMBER 12, 2022

This yield gives us the capacity and scale we need to advance our analytical schedule while also developing our product pipeline,” he added. Optimi will also be using the mushrooms to further develop its on-site extraction methods and will use the product to finalize its naturally derived psilocybin offerings this fall.

History 52

History Clinical Trials Legalization Research and Development 52

The Joint Blog

DECEMBER 9, 2019

The twice-daily administration of plant-derived CBD-dominant extracts is associated with symptom improvement in adolescents with autism spectrum disorder (ASD), according to observational data published in the journal Frontiers in Neurology.

CBD 49

CBD Extraction Epilepsy Sativa 49

The Cannigma

DECEMBER 20, 2021

Researchers are still in the early stages of learning how exactly cannabinoids affect skin health, but some of the results are compelling. Skin disorders such as dermatitis, psoriasis and acne can all greatly affect a patient’s quality of life. But how does cannabis actually affect the skin?

Terpenes 133

Terpenes Cannabinoids Topical Research and Development 133

Cannabis Law Report

DECEMBER 11, 2021

“More than 40,000 patients have used cannabis to treat their respective illnesses. These clinics offer patients two types of medical cannabis: oil extracted from the seeds, and traditional cannabis remedies that use various parts of the plant including the leaves, roots or flowers. Most are cancer patients.

Oil 52

Oil Blood Pressure Concentrates Patients 52

Cannabis Info

MARCH 2, 2019

However, these chains are being repeatedly broken in many areas of the world as many scientific breakthroughs and scores of anecdotal accounts are displaying, that cannabis is a powerful medicinal tool in need of proper research and legal distribution to those in need of its healing. CANNABIS AS A POTENTIAL TREATMENT.

Epilepsy 69

Epilepsy Treatment Marijuana Research and Development 69

Greencamp

APRIL 23, 2019

Canada is one of the countries with the highest numbers of MS patients. For patients who don’t respond well to conventional MS methods, cannabis treatment seems like a very reasonable choice. Although they still can’t say for sure, scientists think that certain genetic and environmental factors play a role in developing MS.

Research and Development 94

Research and Development Strains Patients Treatment 94

The Cannigma

FEBRUARY 24, 2022

He began treating patients with cannabis extracts and wrote of its many clinical applications. The ECS likely developed as an evolutionary advantage to secure vertebrate survival. This isn’t at all specific to humans – data have shown a variety of responses to cannabis across other vertebrates. Bottom line.

Cannabinoids 128

Cannabinoids Research and Development Conditions Cannabis 128

The Joint Blog

MAY 9, 2019

For the study researchers at Queensland University of Technology in Australia and the University of Auckland in New Zeland reviewed over 100 studies assessing health professionals’ opinions with regard to medical cannabis. Health professionals also voiced concern regarding direct patient harms and indirect societal harms.

Research and Development 44

Research and Development Marijuana Medicine Therapy 44

Cannabis Law Report

AUGUST 4, 2021

We thus provide comparison with the pre-pandemic period of H1 2019 as an additional data point. Alongside the Core Business, we remain agile and innovative, developing new solutions to fight the pandemic. Our Core Business has continued to perform very well with strong growth across business lines and geographies. Business Review.

Business 105

Business Research and Development Environment Food 105

Cannabis Law Report

MARCH 3, 2020

MÜV EXTRACT INHALERS, ORAL SPRAYS, AND TINCTURES | Pensacola, Florida Grand Opening, February 15, 2020. Hot coffee, friendly staff, and medical cannabis eagerly greet patients and guests on Feburary 15, 2020 at the Grand Opening of MÜV Dispensary on Ninth Avenue in Pensacola, Florida. . AUTHOR: Heather Allman. Education is key.”

Dispensary 64

Dispensary Patients Cannabis Wellness and Beauty 64